@article{b955381f914841f3b320e0692843b0ed,
title = "Modifying the NSs gene to improve live-attenuated vaccine for Rift Valley fever.",
author = "Olga Lihoradova and Tetsuro Ikegami",
note = "Funding Information: The research to develop an improved MP-12 vaccine has been supported by the National Institute of Allergy and Infectious Diseases, NIH (R01 AI08764301 and 5 U54 AI057156) and Sealy Center for Vaccine Development at The University of Texas Medical Branch. In 2012, O Lihoradova was awarded the Maurice R Hilleman Early-Stage Career Investigator Award by the National Foundation for Infectious Diseases. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.",
year = "2012",
month = nov,
doi = "10.1586/erv.12.106",
language = "English (US)",
volume = "11",
pages = "1283--1285",
journal = "Expert review of vaccines",
issn = "1476-0584",
publisher = "Taylor and Francis Ltd.",
number = "11",
}